enGene Therapeutics Inc.
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Oct 2023 | 0.06x | $2.75 | $0.17 |
| Oct 2024 | 20.71x | $0.32 | $6.65 |
| Oct 2025 | 3.91x | $2.29 | $8.95 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Oct 2023 | 0.06x | $2.75 | $0.17 |
| Oct 2024 | 20.71x | $0.32 | $6.65 |
| Oct 2025 | 3.91x | $2.29 | $8.95 |